Status:

COMPLETED

Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus

Lead Sponsor:

University Hospital, Limoges

Conditions:

Hepatitis B

Renal Failure With Tubular Necrosis

Eligibility:

All Genders

18+ years

Brief Summary

Nucleotide analogues are associated in the long term with a risk of proximal tubular nephropathy (PT) with loss of phosphate, and, when compensatory mechanisms are overwhelmed, with osteopenia or oste...

Detailed Description

260 naive untreated patients, 220 patients treated with TDF and 220 patients treated with ETV and consecutively recruited in this interventional study, will have at baseline and every three months, a ...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Patients with chronic HBV virus monoinfected
  • For groups of patients treated: Patients with an indication of ETV or TDF
  • For the group of naive patients: treatment-naive patients who have no indication of treatment (or do not want) for the duration of the study
  • globular filtration rate (GFR) ≥ 50 ml / min / 1.73 m2 with no known cause of renal disease
  • Patients who have given their informed and written informed consent
  • Women of childbearing potential with an effective method of contraception without interruption for the duration of the research and during the 4 months after stopping treatment

Exclusion

  • Patients co-infected with HIV, hepatitis C or hepatitis Delta
  • Patients who have already received the TDF in the group to receive the TDF and having already received ETV in the group to receive ETV
  • Patient with a GFR \<50 ml / min / 1.73 m2 or with known causes of renal disease
  • Patient with hypophosphatemia \<0.48 mmol / l
  • Patients with hepatocellular carcinoma (diagnosed or suspected)

Key Trial Info

Start Date :

December 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2015

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT01500265

Start Date

December 1 2011

End Date

December 1 2015

Last Update

February 24 2016

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

CHU d'Amiens

Amiens, France, 80054

2

CHU d'Angers

Angers, France, 49933

3

CHU de Besancon

Besançon, France, 25000

4

CHU de Bordeaux - Hôpital Saint André

Bordeaux, France, 33000